TAPIMMUNE INTELLECTUAL PROPERTY

OWNED BY TAPIMMUNE

Transporter Associated with Antigen Processing (TAP)

Issued:

Title: Method of enhancing expression of MHC class I molecules bearing endogenous peptides; issued March 26, 2002 as U.S. 6,361,770

Title: Method of enhancing and immune response; issued May 27, 2008 as U.S. 7,378,087

Title: Method of enhancing an immune response; issued August 11, 2011 as U.S. 7,994,146

Title: Pox viridae treatment; issued July 12, 2011 as U.S. 7,976,850

Title: Method of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathway; issued August 11, 1998 as U.S. 5,792,604

Applications:

Title: Method of enhancing an immune response; filed June 27, 2011 as Application Number 13/169159

Title: Method for enhancing an immune response; filed January 16, 2002 as Application Number 10/046542

Title: Method of enhancing an immune response; filed February 11, 2008 as Application Number 12/029080

Title: Method of enhancing an immune response; filed March 11, 2011 as Application Number 13/046038

Title: Pox viridae treatment; filed May 29, 2009 as Application Number 12/474,331

Title: Tapasin augmentation for enhanced immune response; filed January 27, 2009 as Application Number 12/864751, National stage of PCT/IB09/05030

Title: Low dose inoculation with TAP for anti-tumor immunity; filed June 18, 2009 as Application Number 12/48701

PolyStartâ„¢

Applications:

Title: Chimeric nucleic acid molecule with non-AUG translation initiation sequences; issued as US 9,364,523 B2, June 14, 2016

Title: Chimeric nucleic acid molecule with non-AUG translation initiation sequences and uses thereof; Notice of allowance January 19, 2017

 

EXCLUSIVE LICENSE FROM MAYO FOUNDATION

Folate Receptor Alpha

Issued:

Title: Immunity to folate receptors; issued July 16, 2013 as U.S. Patent Number 8,486,412

Applications:

Title: Immunity to folate receptors, filed July 13, 2013 as Application Number 13/917410

Her2/neu

Applications:

Title: HLA-DR Binding peptides and their uses, filed August 24, 2010 as U.S. Application Number 12/740562 [Corresponding International Applications in Japan, China, Canada and EEC]

Title: Methods and materials for generating CD8+ cells having the ability to recognize cancer cells expressing a Her2/neu polypeptide, filed February 15, 2013 as PCT/US2013/026484